Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway
Feng Bai(Shanxi Medical University), Xin‐Hai Pei(Chinese Academy of Medical Sciences & Peking Union Medical College), Sijia Ren(Zhejiang University), Wei‐Guo Zhu(Shenzhen University), Jason I. Herschkowitz(Baylor College of Medicine), Daniel P. Hollern(University of North Carolina at Chapel Hill), Chang Liu(China Pharmaceutical University), Xiong Liu(Shenzhen University Health Science Center), Shiqin Liu(University of California, Los Angeles), Cheng Fan(University of North Carolina at Chapel Hill), Chuying Wang(Guilin University of Electronic Technology)
Cited by 24
Related Papers
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Evaluating the comparability of gene expression in blood and brain
|American Journal of Medical Genetics Part B Neuropsychiatric Genetics|2006|616